FRBRX
Price
$190.06
Change
-$0.82 (-0.43%)
Updated
Nov 19 closing price
Net Assets
1B
FSPHX
Price
$30.27
Change
+$0.15 (+0.50%)
Updated
Nov 19 closing price
Net Assets
6.22B
Interact to see
Advertisement

FRBRX vs FSPHX

Header iconFRBRX vs FSPHX Comparison
Open Charts FRBRX vs FSPHXBanner chart's image
Franklin Biotechnology Discovery R6
Price$190.06
Change-$0.82 (-0.43%)
VolumeN/A
Net Assets1B
Fidelity Select Health Care
Price$30.27
Change+$0.15 (+0.50%)
VolumeN/A
Net Assets6.22B
FRBRX vs FSPHX Comparison Chart in %
View a ticker or compare two or three
VS
FRBRX vs. FSPHX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FRBRX is a Hold and FSPHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. FRBRX (1B). FSPHX pays higher dividends than FRBRX: FSPHX (0.02) vs FRBRX (0.00). FRBRX was incepted earlier than FSPHX: FRBRX (13 years) vs FSPHX (44 years). FRBRX (0.77) is less costly to investors than FSPHX (0.63). FSPHX is a more actively managed with annual turnover of: 40.00 vs. FRBRX (21.87). FSPHX has a lower initial minimum investment than FRBRX: FSPHX (0) vs FRBRX (1000000). FRBRX annual gain was more profitable for investors over the last year : 31.95 vs. FSPHX (0.02). FRBRX return over 5 years is better than : 1.39 vs. FSPHX (-8.84).
FRBRXFSPHXFRBRX / FSPHX
Total Expense Ratio0.670.63106%
Annual Report Gross Expense Ratio0.770.63122%
Fund Existence13 years44 years-
Gain YTD47.66010.532453%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1B6.22B16%
Annual Yield % from dividends0.000.02-
Returns for 1 year31.950.02189,010%
Returns for 3 years67.6710.47646%
Returns for 5 years1.39-8.84-16%
Returns for 10 years9.5439.3424%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVTCX55.320.24
+0.44%
Calamos Growth & Income C
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.66N/A
N/A
Bruce
REMVX11.03N/A
N/A
RBC Emerging Markets Value Equity I
SPMHX8.48N/A
N/A
Invesco SteelPath MLP Alpha R5